David Hallal

CIK 1457477 · Chief Executive Officer · last filed 2026-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$82.08M

Companies

5

Total Filings

112

Lifetime Open-Market Net

-$16.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KLRS Director $4.33 $0 2 2026-06-04
SRRK Chief Executive Officer 1,844,034 $44.18 $81.47M -$3.97M 15 2026-04-20
iTeos Therapeutics, Inc. (ITOS) Delisted Director 0 $10.15 $0 -$3.94M 9 2025-08-29
SEER Director 355,128 $1.72 $610.8K $0 5 2024-06-14
Kalaris Therapeutics, Inc. (ALVR) Delisted Director 2,281,815 $9.81 $22.38M -$8.93M 15 2024-06-07

Recent Filings · Page 5 of 12

112 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-07-31 Kalaris Therapeutics, Inc. (ALVR) Delisted Grant (A) $0 EDGAR
2020-07-24 iTeos Therapeutics, Inc. (ITOS) Delisted Grant (A) $0 EDGAR
2020-06-18 SRRK Grant (A) $0 EDGAR
2019-09-20 SRRK Gift (G) −2,000 $0 EDGAR
2019-05-23 SRRK Grant (A) $0 EDGAR
2018-06-26 SRRK Grant (A) $0 EDGAR
2016-08-10 Sell (S) −332 -$45.5K
2016-04-05 Sell (S) −1,414 -$192.1K
2016-03-01 Mixed +17,986 -$279.8K
2016-02-08 Mixed +29,839 -$1.59M
Showing 4150 of 112
Page 5 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.